15
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Trial of a Selective Acetylcholinesterase Inhibitor, Galanthamine Hydrobromide, in the Treatment of Chronic Fatigue Syndrome

, &
Pages 35-54 | Published online: 04 Dec 2011

References

  • Sharpe MC, Archard LC, Banatvala JE, et al. Chronique fatigue syndrome: guidelines for research. Journal of the Royal Society of medicine. 1991;84:118–21.
  • Schluedeberg A, Straus SE, Peterson P, et at. Chronic Fatigue Syndrome Research. Definition and Medical Outcome Assessment. Ann Intern Med, 1992; 117:325–331.
  • Shafran SD. The Chronique Fatigue Syndrome. Am J Med, 1991; 90: 730–39
  • Kroenke K, Wood DO, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care: Prevalence, patients characteristics, and outcome. JAM A 1989; 260: 929–934.
  • Bickel Ii, Thomsen T, Fischer JP, et al. Galanthamine pharmacokinetics and inhibition of cholinesterase in humans. In Kewitz H, et al., ed. Pharmacologi-cal intervention on central cholinergic mechanisms in senile dementia. W. Zuck-schwerclt Verlag Munich 1989; 280–83.
  • Cozantis DA. Galanthamine hydrobromide versus neostigmine. A plasma cortisol study in man. Anaesthesia, 1974; 29: 163–168.
  • Snorrason E, Stcfanason JO. Galanthiunine in mania. Lancet 1991; 337: 67.
  • Göpel W, Bertram W. Erfahrungen mit Nivalin in der neurologischen ther-apie. Bertcht uber 100 Falie. Psychiatrie, Neurologie, medizinischen Psychologie. 1971; 23: 712–718.
  • Rainer M, Mark Th, Haushofer A. Galanthamine hydrobromide in the treatment of senile dementia of Alzheimer's type. In Kewitz et al., ed. Pharmaco-logical interventions on central cholinergic mechanisms in senile dementia. W. Zuckschwerdt Verlag, Munich 1989; pp. 223–237.
  • Thomsen T, Kewitz H. Selective inhibition of human acetyleholinesterase by galanthamine in vitro and in vivo. Life Sciences. 1990; 46: 1553–1558.
  • Spielberg CD. State-Trait Anxiety Inventory. Consulting Psychologists Press, Inc.,Palo Alto, 1985.
  • Wechsler D, Stone CP. Wechsler Memory Scale. New York, Psychological Corporation, 1973.
  • Broadbent DE, Cooper PJ, et al. The cognitive failures questionnaire (CFQ) and its correlates. Brit. J. Clin. Psycho]. 1982; 21: 1–6.
  • DIS-111-A Scales. The American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-111-R) Third Edition. Am. Psych. Assoc., Washington, D.C.: 1987.
  • Cozanitis DA, Friedman T, Furst S. Study of the analgesic effects of galan-thamine a cholinesterase inhibitor. Arch Int Phannacodyn Ther 1983; 266: 229–238.
  • Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syn-drome. J Clin Endocrinol Metabol. 1991; 73: 1224–1234.
  • Clark S, Tindall E, Bennett RM. A double blind crossover trial of predni-sone versus placebo in the treatment of fibrositis. J Rheumatol 1985; 12: 980–983.
  • Drachinan DB. Myasthenia gravis. N Eng J Med 1978; 98: 186–193,
  • Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993, Jan.; 43; 125–131,
  • Moldowsky H, Saskin P, Lue FA. Sleep and symptoms in fibrositis after a febrile illness. J Rheumatol 1988; 15: 1701–1704.
  • Papazian O. Rapid eye movement sleep alteration in myasthenia gravis. Neurology 1976; 26: 311–316.
  • Gann H, Riemann D, Dressing H, Muller WE, Aldenloff J13. The influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. For submission in Psychiatric Research. Personal communication.
  • Hobson JA, Lydic R, Baghdoyan HA, Evolving concepts of sleep cycle generation: From brain centers to neuronal populations. Behavioral and Brain Sciences. 1986; 9: 371–448.
  • Buchwald D, Jones J, and Levine PH. Summary. Clinical and Multidisci-plinary Research on Chronic Fatigue Syndrome. Clin. Infect. Dis. 1994; 18,1: S115–S116.
  • Stefiinsson JG, Linda EL, 13jörnsson JK, GuOmundsdettir A. The Lifetime prevalence of specific mental disorders among persons born in Iceland 1931. Acta Psychiatrica Scandanavia, 1991; 84, 142–149.
  • Katon WJ, Buchwald DS, Simon GE, Russon JE, Mease PJ. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. Journal of General Internal Medicine, 1991; 6:277–285.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.